Brand-name semaglutide
Wegovy® for weight loss
Wegovy® is Novo Nordisk's brand-name injectable semaglutide, FDA-approved for chronic weight management. Temi helps patients review available GLP-1 care with a licensed clinician, including FDA-approved brand options and compounded preparations if clinically appropriate.
Start with a Temi clinician
Where are you with Wegovy®? Submitting a request starts a clinician review. It is not a guarantee that anything will be prescribed.